Novo CEO pressed by Senate to cut price ranges of weight problems, diabetic issues drugs CEO Lars Fruergaard Jørgensen told lawmakers the company would look at new talks with insurers in regards to the checklist selling prices of Wegovy and Ozempic when they pledge to help keep the medicines on https://busch-light-peach-nutriti53074.mdkblog.com/36361641/healthcare-news-an-overview